Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.
Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to see if magnesium can reduce the number of shocks patients
with ICDs experience and to see if magnesium supplementation improves patients quality of
life.